Clinical Trial Update: Tirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating tirelizumab with chemotherapy for HER2-negative locally advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Tirelizumab (tirelizumab)

Snippet

Sponsor: Lin Chen | Conditions: Locally Advanced Gastric Carcinoma, HER2 Negative | Phase 2 | Status: UNKNOWN